New Delhi, March 30 Alembic Pharmaceuticals Ltd announced on Monday that it has received final approval from the US health regulator for its generic version of Paroxetine extended-release tablets, indicated for various mental health conditions.The approval from the US Food & Drug...
alembic pharmaceuticals
extended-release tablets
generic drugs
major depressive disorder
mental health
panic disorder
paroxetine
premenstrualdysphoricdisorder
social anxiety disorder
supplemental abbreviated new drug application (sanda)
usfda